[go: up one dir, main page]

DK2306988T3 - PHARMACEUTICAL FORMULA FOR TREATMENT OF THE UPPER digestive tract - Google Patents

PHARMACEUTICAL FORMULA FOR TREATMENT OF THE UPPER digestive tract

Info

Publication number
DK2306988T3
DK2306988T3 DK09800023.5T DK09800023T DK2306988T3 DK 2306988 T3 DK2306988 T3 DK 2306988T3 DK 09800023 T DK09800023 T DK 09800023T DK 2306988 T3 DK2306988 T3 DK 2306988T3
Authority
DK
Denmark
Prior art keywords
treatment
digestive tract
upper digestive
pharmaceutical formula
pharmaceutical
Prior art date
Application number
DK09800023.5T
Other languages
Danish (da)
Inventor
Rudolf Wilhelm
Markus Proels
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2306988(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Application granted granted Critical
Publication of DK2306988T3 publication Critical patent/DK2306988T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Effervescent tablet (I) comprises budesonide. ACTIVITY : Antiinflammatory; Gastrointestinal-Gen.; Immunosuppressive. MECHANISM OF ACTION : None given.
DK09800023.5T 2008-07-21 2009-07-02 PHARMACEUTICAL FORMULA FOR TREATMENT OF THE UPPER digestive tract DK2306988T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08013091A EP2151235B1 (en) 2008-07-21 2008-07-21 Pharmaceutical formulation for treating the upper digestive tract
PCT/EP2009/058320 WO2010009961A1 (en) 2008-07-21 2009-07-02 Pharmaceutical formulation for treating the upper digestive tract

Publications (1)

Publication Number Publication Date
DK2306988T3 true DK2306988T3 (en) 2013-03-18

Family

ID=39951664

Family Applications (2)

Application Number Title Priority Date Filing Date
DK08013091.7T DK2151235T3 (en) 2008-07-21 2008-07-21 Pharmaceutical formulation for treating the upper digestive tract
DK09800023.5T DK2306988T3 (en) 2008-07-21 2009-07-02 PHARMACEUTICAL FORMULA FOR TREATMENT OF THE UPPER digestive tract

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK08013091.7T DK2151235T3 (en) 2008-07-21 2008-07-21 Pharmaceutical formulation for treating the upper digestive tract

Country Status (23)

Country Link
US (2) US8580300B2 (en)
EP (2) EP2151235B1 (en)
JP (2) JP5616889B2 (en)
CN (1) CN102159196B (en)
AT (1) ATE498396T1 (en)
AU (1) AU2009273361B2 (en)
CA (1) CA2731312C (en)
CY (2) CY1111878T1 (en)
DE (1) DE502008002621D1 (en)
DK (2) DK2151235T3 (en)
EA (1) EA018465B1 (en)
ES (2) ES2358158T3 (en)
HR (2) HRP20130171T1 (en)
IL (1) IL210779A (en)
ME (2) ME01256B (en)
NZ (1) NZ590593A (en)
PL (2) PL2151235T3 (en)
PT (2) PT2151235E (en)
RS (2) RS51649B (en)
SI (2) SI2151235T1 (en)
UA (1) UA100759C2 (en)
WO (1) WO2010009961A1 (en)
ZA (1) ZA201100283B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1183014T3 (en) 1999-06-14 2004-02-09 Cosmo Spa Flavored controlled release oral pharmaceutical compositions
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP2151235B1 (en) * 2008-07-21 2011-02-16 Dr. Falk Pharma Gmbh Pharmaceutical formulation for treating the upper digestive tract
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
PT3403654T (en) 2009-10-01 2019-09-05 Adare Dev I L P Orally administered corticosteroid compositions
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
EP2886108B2 (en) * 2013-12-23 2022-11-02 Dr. Falk Pharma Gmbh Optimised pharmaceutical formula for the treatment of inflammatory changes of the esophagus
TWI777515B (en) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 Methods of treating eosinophilic esophagitis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332394A1 (en) 1993-09-23 1995-03-30 Falk Pharma Gmbh Controlled release budesonide pellets and method of making the same
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP3818789B2 (en) * 1999-02-18 2006-09-06 三菱化学フーズ株式会社 Easily disintegrating tablets
WO2003006629A1 (en) 2001-07-11 2003-01-23 Toshirou Sekine Culturing method and device for photosynthetic microbes
EP1432410A2 (en) * 2001-09-25 2004-06-30 Ranbaxy Laboratories, Ltd. Process for the preparation of fast dissolving effervescent dosage form
AU2002348301B2 (en) * 2001-11-20 2008-05-08 Dmi Biosciences, Inc. Methods and products for oral care
US20030215502A1 (en) * 2002-03-20 2003-11-20 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
SE0401031D0 (en) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060013873A1 (en) * 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
JP2009526619A (en) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー Sterilization of corticosteroids with weight loss
PT2170348T (en) * 2007-06-22 2016-11-02 Dompé Farm S P A Effervescent tablets for inhalatory use
PL2572705T3 (en) * 2007-10-01 2018-01-31 Lesvi Laboratorios Sl Orodispersible tablets
EP2151235B1 (en) * 2008-07-21 2011-02-16 Dr. Falk Pharma Gmbh Pharmaceutical formulation for treating the upper digestive tract
WO2010144865A2 (en) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders

Also Published As

Publication number Publication date
RS51649B (en) 2011-10-31
US20140079646A1 (en) 2014-03-20
JP2011528679A (en) 2011-11-24
DE502008002621D1 (en) 2011-03-31
AU2009273361B2 (en) 2014-03-20
EA201100229A1 (en) 2011-08-30
PT2306988E (en) 2013-02-15
IL210779A (en) 2015-07-30
CA2731312A1 (en) 2010-01-28
CN102159196A (en) 2011-08-17
CA2731312C (en) 2016-05-10
UA100759C2 (en) 2013-01-25
ATE498396T1 (en) 2011-03-15
HRP20110208T1 (en) 2011-04-30
RS52662B (en) 2013-06-28
JP5616889B2 (en) 2014-10-29
PL2306988T3 (en) 2013-04-30
EP2306988B1 (en) 2013-01-09
ES2399321T3 (en) 2013-03-27
JP2014221827A (en) 2014-11-27
ME01494B (en) 2014-04-20
EP2151235B1 (en) 2011-02-16
EA018465B1 (en) 2013-08-30
EP2151235A1 (en) 2010-02-10
ES2358158T3 (en) 2011-05-06
EP2306988A1 (en) 2011-04-13
PL2151235T3 (en) 2011-05-31
ZA201100283B (en) 2011-10-26
SI2306988T1 (en) 2013-03-29
CN102159196B (en) 2013-05-08
SI2151235T1 (en) 2011-04-29
HRP20130171T1 (en) 2013-03-31
NZ590593A (en) 2012-07-27
IL210779A0 (en) 2011-03-31
US8580300B2 (en) 2013-11-12
WO2010009961A1 (en) 2010-01-28
DK2151235T3 (en) 2011-04-11
ME01256B (en) 2013-06-20
PT2151235E (en) 2011-03-21
AU2009273361A1 (en) 2010-01-28
HK1149907A1 (en) 2011-10-21
CY1111878T1 (en) 2015-11-04
JP6209495B2 (en) 2017-10-04
US20110123460A1 (en) 2011-05-26
CY1113719T1 (en) 2016-06-22

Similar Documents

Publication Publication Date Title
DK2306988T3 (en) PHARMACEUTICAL FORMULA FOR TREATMENT OF THE UPPER digestive tract
LTC2137143I2 (en) PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF MICROBIAL DISEASES
IL255752B (en) Compounds, pharmaceutical preparations containing the same uses for the treatment of cardiovascular disease, inflammatory diseases and cancer
EP2440210A4 (en) METHODS OF TREATING GASTROINTESTINAL DISORDERS
DK2491942T3 (en) Use of cell permeable peptide inhibitors by the JNK signal transduction pathway for the treatment of various cardiovascular diseases.
WO2009014650A3 (en) Recombinant vibrio cholerae exotoxins
LTC1781298I2 (en) Pharmaceutical compositions containing benzoxazine for the treatment of respiratory diseases
DK2056842T3 (en) Modified galactosylceramide for the treatment of cancerous diseases
FR2953142B1 (en) APPARATUS FOR REGULATED DELIVERY OF GAS, ESPECIALLY RESPIRATORY ASSISTANCE APPARATUS
FR2928832B1 (en) WRIST ORTHESIS FOR THE TREATMENT OF CARPENTAL CANAL SYNDROME
DK1937633T3 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory diseases
CL2008002384A1 (en) Compounds derived from quinolinyloxypiperidine and pyrrolidine, pharmaceutical composition, pharmaceutical combination, useful for the treatment of inflammatory and / or allergic diseases of the respiratory tract.
DK2022504T3 (en) Ointment for the treatment of hemorrhoids
CL2007003875A1 (en) COMPOUNDS DERIVED FROM AMIDAS OF THE 3-AMINO TETRAHYDROFURAN-3-CARBOXYL ACID; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS.
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
DK2296651T3 (en) 5-HYDROXYMETHYL-OXAZOLIDIN-2-ON DERIVATIVES FOR THE TREATMENT OF BACTERIAL INTESTINAL DISEASES
CY2016019I1 (en) THERAPEUTIC TREATMENT OF ME CAMPATH-1H ME CAMPATH-1H
DK1940409T3 (en) New drug combinations for the treatment of respiratory diseases
ZA200809858B (en) Delayed-release glucocorticoid treatment of rheumatoid disease
DE502008002255D1 (en) Medicament containing female coat for the treatment of endometritis, vaginitis
FR2910081B1 (en) APPARATUS FOR REGULATED DELIVERY OF GAS, ESPECIALLY RESPIRATORY ASSISTANCE APPARATUS
DK1856070T3 (en) New drugs for the treatment of respiratory diseases
NO20090292L (en) phenylacetic
DK2344166T3 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF GASTROINTESTINAL IRRITATION DISEASES
UA32952U (en) Chystofil composition for treating diseases of gastrointestinal tract, liver and biliary tracts